|
SAP18 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.73190034430593E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.23910009925044E-10 |
| Normal-vs-Stage2 |
8.437700E-03 |
| Normal-vs-Stage3 |
4.015600E-04 |
| Normal-vs-Stage4 |
1.065350E-01 |
| Stage1-vs-Stage2 |
4.096400E-01 |
| Stage1-vs-Stage3 |
8.624800E-01 |
| Stage1-vs-Stage4 |
3.838600E-01 |
| Stage2-vs-Stage3 |
6.439400E-01 |
| Stage2-vs-Stage4 |
8.621200E-01 |
| Stage3-vs-Stage4 |
5.859200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.45610009897268E-10 |
| Normal-vs-AfricanAmerican |
3.66240000004847E-06 |
| Normal-vs-Asian |
9.382300E-02 |
| Caucasian-vs-AfricanAmerican |
4.699200E-01 |
| Caucasian-vs-Asian |
7.505200E-01 |
| AfricanAmerican-vs-Asian |
5.962200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.21090004689961E-09 |
| Normal-vs-Female |
7.69510000164786E-09 |
| Male-vs-Female |
3.801800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.212400E-04 |
| Normal-vs-Extreme_Weight |
9.70759994611825E-09 |
| Normal-vs-Obese |
2.398899999978E-06 |
| Normal-vs-Extreme_Obese |
7.075800E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.520000E-01 |
| Normal_Weight-vs-Obese |
8.638000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.804000E-01 |
| Extreme_Weight-vs-Obese |
7.873600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.134800E-01 |
| Obese-vs-Extreme_Obese |
9.412000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.35589991959273E-10 |
| Normal-vs-Age(41-60Yrs) |
1.03080000002365E-06 |
| Normal-vs-Age(61-80Yrs) |
3.36309868842477E-11 |
| Normal-vs-Age(81-100Yrs) |
3.217800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.644700E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.402000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.112500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.600400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.747800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.742600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.59319998807683E-09 |
| Normal-VS-Type2 PRCC |
1.58580999999325E-05 |
| Normal-VS-KIRP CIMP |
1.96810012731419E-10 |
| Normal-VS-Unclassified PRCC |
1.43089999959933E-07 |
| Type1 PRCC-VS-Type2 PRCC |
8.700400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.995400E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.799600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.057500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.662800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.324720E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.153800E-04 |
| Normal-vs-N1 |
1.562010E-03 |
| Normal-vs-N2 |
1.43330000001995E-06 |
| N0-vs-N1 |
5.276200E-01 |
| N0-vs-N2 |
5.484000E-02 |
| N1-vs-N2 |
1.307450E-01 |
|
|
